Cardiac hemodynamic response to the 6-minute walk test in patients with intestinal carcinoma undergoing bevacizumab treatment | Zendy

Huiling Huang | Zendy; Yalin Cao | Zendy; Yugang Dong | Zendy; Jiayong Li | Zendy; Chen Liu | Zendy; Marvin Owusu-Agyema | Zendy; Yao Tong | Zendy; Fengjuan Yao | Zendy; Baolin Chen | Zendy; Ling Li | Zendy; Fawang Du | Zendy; Xingwei Hu | Zendy; Xing Wang | Zendy; Yanhong Deng | Zendy

Open Access

Cardiac hemodynamic response to the 6-minute walk test in patients with intestinal carcinoma undergoing bevacizumab treatment

Author(s) -

Huiling Huang,

Yalin Cao,

Yugang Dong,

Jiayong Li,

Chen Liu,

Marvin Owusu-Agyema,

Yao Tong,

Fengjuan Yao,

Baolin Chen,

Ling Li,

Fawang Du,

Xingwei Hu,

Xing Wang,

Yanhong Deng

Publication year - 2020

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-20-435

Subject(s) - medicine , hemodynamics , bevacizumab , cardiac index , cardiac output , stroke volume , ejection fraction , heart rate , haemodynamic response , cardiology , chemotherapy , blood pressure , heart failure

Exercise capacity is evaluated using the 6-minute walk test (6MWT) in various cardiovascular diseases. Bevacizumab (BEV) has been associated with significant risk of cardiovascular complications. The aim of this study was to investigate BEV-related influences on cardiac hemodynamic response to 6MWT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research